We are live on
!
Find out more
FAT
First American Trust Portfolio holdings
AUM
$1.49B
1-Year Est. Return
21.98%
This Fund
S&P 500
This Quarter
Est. Return
+5.4%
1 Year Est. Return
+21.98%
3 Year Est. Return
+75.41%
5 Year Est. Return
+98.06%
10 Year Est. Return
+373.27%
AUM
$406M
AUM Growth
+$23.4M
(+6.1%)
Cap. Flow
+$4.17M
Cap. Flow
% of AUM
1.03%
Top 10 Holdings %
Top 10 Hldgs %
33.15%
Holding
130
New
18
Increased
48
Reduced
39
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$3.25M |
| 2 |
APC
Anadarko Petroleum
APC
|
+$3.05M |
| 3 |
Baker Hughes
BKR
|
+$2.86M |
| 4 |
Ulta Beauty
ULTA
|
+$2.71M |
| 5 |
O'Reilly Automotive
ORLY
|
+$2.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.97M |
| 2 |
AGN
Allergan plc
AGN
|
+$3.92M |
| 3 |
Edison International
EIX
|
+$3.43M |
| 4 |
Incyte
INCY
|
+$2.61M |
| 5 |
CLGX
Corelogic, Inc.
CLGX
|
+$2.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.72% |
| 2 | Consumer Discretionary | 9.5% |
| 3 | Healthcare | 9.42% |
| 4 | Technology | 8.19% |
| 5 | Communication Services | 6.25% |
Similar funds
OA
AIA
LFS
PIM
NAM
RIM
SB
MCM
First American Trust's Q4 2017 Portfolio in Review
As of Q4 2017, First American Trust held 130 positions worth $406M, up 6.1% from $383M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
First American Trust's Q4 2017 filing shows 18 new, 48 increased, 39 reduced and 11 closed positions. Its largest new stake was Biogen: 10,129 shares worth $3.23M. The largest sale was Alexion Pharmaceuticals, an estimated $3.97M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- First American Trust's largest Q4 2017 buy was Biogen: 10,129 shares worth $3.23M.
- First American Trust added most to Pfizer in Q4 2017, an estimated $2.37M increase.
- First American Trust's biggest Q4 2017 reduction was Edison International, cutting an estimated $3.43M.
- First American Trust fully exited Alexion Pharmaceuticals in Q4 2017, selling an estimated $3.97M.
- First American Trust's ten largest holdings make up 33% of its $406M portfolio in Q4 2017.
- First American Trust opened 18 new positions and closed 11 in Q4 2017.
- First American Trust's portfolio value rose 6.1% quarter-over-quarter to $406M.
Based on First American Trust's 13F filing for Q4 2017, filed 11 Jan 2018.